Rupatadine is a dual histamine H1 receptor and platelet activating factor receptor antagonist that is used for symptomatic relief in seasonal and perennial rhinitis as well as chronic spontaneous urticaria. It was approved for marketing in Canada under the tradename Rupall and comes in tablet formulation for adult use and liquid formulation for pediatric use. Its therapeutic use is listed as antihistamines. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Rinialer, Rupax and UR-12592. Its PubChem CID is 133017.
Rupatadine
| CAS No | 158876-82-5 |
|---|---|
| Molecular Formula | C26H26ClN3 |
| Molecular Weight | 416.0 g/mol |
| Synonyms | 13-chloro-2-[1-[(5-methylpyridin-3-yl)methyl]piperidin-4-ylidene]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Rupatadine is a dual histamine H1 receptor and platelet activating factor receptor antagonist that is used for symptomatic relief in seasonal and perennial rhinitis as well as chronic spontaneous urticaria.
The listed CAS number is 158876-82-5.
The listed molecular formula is C26H26ClN3.
The listed molecular weight is 416.0 g/mol.
13-chloro-2-[1-[(5-methylpyridin-3-yl)methyl]piperidin-4-ylidene]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene.
The source lists Rinialer, Rupax and UR-12592.